A. Bress

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
Adam Bress, A.p. Bress, A Bress, Adam P. Bress, A P Bress, Adam P Bress, Adam Phillip Bress, A. P. Bress
Publication record
245 papers · 4,169 citations · H-index 36

PAPERS

Small But Mighty: Blood Pressure Control Through Ultra-Low-Dose Single-Pill Antihypertensive Medication as Initial Therapy.
20260 citationsauthor #3
Impact of a Smartwatch Hypertension Notification Feature for Population Screening.
20261 citationsauthor #8
Self-perceived bodyweight status among adults who are overweight or have obesity, with and without high cardiovascular risk
20260 citationsauthor #4
Approaching Drug Choices and Challenges for the Management of Hypertension.
20250 citationsauthor #1
EFFECT OF INTENSIVE VERSUS STANDARD SYSTOLIC BLOOD PRESSURE CONTROL FOR PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE BY PREVENT RISK SCORE LEVELS: A SECONDARY ANALYSIS OF SPRINT
20250 citationsauthor #11
Effect of Initiation and Continuous Adherence to ARBs Versus ACEIs on Risk of Adjudicated Mild Cognitive Impairment or Dementia
20255 citationsauthor #14
Correction to: 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guideline
20259 citationsauthor #10
2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
202512 citationsauthor #10
Initiation of ARB- vs ACEI-Based Antihypertensive Medication Regimens and Differences in Rates of Cognitive Decline
20250 citationsauthor #13
Geographic access to community pharmacies based on walking, driving, and public transportation in the 10 most populated U.S. areas.
20250 citationsauthor #3
Accelerating Clinical NLP at Scale with a Hybrid Framework with Reduced GPU Demands: A Case Study in Dementia Identification
20250 citationsauthor #6
Correction to: 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guideline
202513 citationsauthor #10
Effect of Intensive Systolic Blood Pressure Control on Markers of Cerebral Small Vessel Disease by Age.
20250 citationsauthor #3
Using PREVENT Equations to Compare Intensive vs Standard Systolic Blood Pressure Control for Primary Prevention in SPRINT.
20251 citationsauthor #11
REAL-WORLD ANTIHYPERTENSIVE TREATMENT ESCALATION AFTER INITIAL MONOTHERAPY IN THE VETERANS HEALTH ADMINISTRATION
20250 citationsauthor #12
Income, Race-Ethnicity, and Dementia Risk Factors in the United States.
20250 citationsauthor #8
Epigenetic Aging: A Mechanism by Which Social Determinants Increase the Risk of Hypertension?
20250 citationsauthor #3
ANTIHYPERTENSIVE MEDICATION DISCONTINUATION RATES BY INITIAL MONO- AND COMBINATION THERAPY USE IN THE VETERANS HEALTH ADMINISTRATION, 2000-2022
20250 citationsauthor #7
RACIAL, ETHNIC AND SEX DIFFERENCES IN ATHEROSCLEROTIC CARDIOVASCULAR DISEASE RISK AMONG US CANCER SURVIVORS: INSIGHTS FROM THE NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY
20250 citationsauthor #6
Trends in Initial Combination Antihypertensive Therapy in a US Health System.
20250 citationsauthor #12
ANTIHYPERTENSIVE MEDICATION CO-PAY AND ADHERENCE AMONG VETERANS RECEIVING CARE WITHIN THE VETERANS HEALTH ADMINISTRATION
20250 citationsauthor #8
2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
202521 citationsauthor #10
First-Line β-Blocker Use for Hypertension in the Veterans Health Administration
20250 citationsauthor #13
High-Density Lipoprotein Cholesterol and Statin Use Among U.S. Adults With Intermediate 10-Year Predicted ASCVD Risk
20252 citationsauthor #3
2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
2025130 citationsauthor #10
Association of ambient temperature and blood pressure in the Jackson Heart Study
20251 citationsauthor #4
Use of Censored Data Methods to Estimate Blood Pressure Percentiles in US Adults.
20240 citationsauthor #4
Knowledge of Risk Factors for Dementia and Attitudes on a Dementia Prevention Program by Age and Ethnicity in Arizona
20240 citationsauthor #3
Association Between Self-Reported Medication Adherence and Therapeutic Inertia in Hypertension: A Secondary Analysis of SPRINT (Systolic Blood Pressure Intervention Trial).
20245 citationsauthor #11
Quantifying antihypertensive effects of GLP-1 agonists.
20242 citationsauthor #2
PRESCRIPTION TURNAROUNDS IN US ANTIHYPERTENSIVE MEDICATION PRESCRIBING FROM 1996 THROUGH 2020
20240 citationsauthor #9
Cost of Cardiovascular Disease Event and Cardiovascular Disease Treatment–Related Complication Hospitalizations in the United States
20248 citationsauthor #7
Pharmacologic Treatment of Hypertension in Older Adults
20243 citationsauthor #6
Optimal Initial Intravenous Loop Diuretic Dosing in Acute Decompensated Heart Failure
20245 citationsauthor #12
Annual Cost of Implementing Intensive Systolic Blood Pressure Goals in the United States
20241 citationsauthor #17
Association Between Caregiver Strain and Self‐Care Among Caregivers With Hypertension: Findings From the REGARDS Study
20243 citationsauthor #7
Effectiveness of Hypertension Management Strategies in SPRINT‐Eligible US Adults: A Simulation Study
20245 citationsauthor #6
Social Determinants of Health and Disparities in Guideline-Directed Medical Therapy Optimization for Heart Failure
20248 citationsauthor #3
Insulin Glargine Compared with Glucagon-Like Peptide 1 Receptor Agonists (GLP-1 RAs) or SGLT2 Inhibitors Is Associated with Higher Risk of Alzheimer Disease and Alzheimer Disease-Related Dementias (AD/ADRD) in CKD
20240 citationsauthor #5
Trends in Initial Antihypertensive Medication Prescribing Among >2.8 Million Veterans Newly Diagnosed With Hypertension, 2000 to 2019
20242 citationsauthor #12
Association Between Pharmacy Proximity With Cardiovascular Medication Use and Risk Factor Control in the United States
20242 citationsauthor #13
The Legacy Effect of Intensive versus Standard BP Control on the Incidence of Needing Dialysis or Kidney Transplantation
202410 citationsauthor #3
β-Amyloid Positron Emission Tomography Use Across Medicare Administrative Contractor Regions.
20240 citationsauthor #3
The Management of Elevated Blood Pressure in the Acute Care Setting: A Scientific Statement From the American Heart Association
202439 citationsauthor #1
Use and Cost Patterns of Antihypertensive Medications in the United States From 1996 to 2021
20246 citationsauthor #12
Access to community pharmacies based on drive time and by rurality across the contiguous United States.
202417 citationsauthor #5
Abstract MP74: Ambient Temperature and Blood Pressure Are Associated in the Jackson Heart Study
20240 citationsauthor #4
Newer glucose‐lowering drugs and risk of dementia: A systematic review and meta‐analysis of observational studies
202372 citationsauthor #8
Age-based disparities in statin use for primary prevention in US adults: National Health and Nutrition Examination Surveys 2013-2020.
20230 citationsauthor #6
Evidence for Age Bias Contributing to Therapeutic Inertia in Blood Pressure Management: A Secondary Analysis of SPRINT
20238 citationsauthor #12
Discontinuation of renin-angiotensin system inhibitors during the early stage of the COVID-19 pandemic.
20230 citationsauthor #6
Prevalence of Statin Use for Primary Prevention of Atherosclerotic Cardiovascular Disease by Race, Ethnicity, and 10-Year Disease Risk in the US: National Health and Nutrition Examination Surveys, 2013 to March 2020.
202367 citationsauthor #12
Entering a New Era of Antihypertensive Therapy.
20236 citationsauthor #2
Antihypertensive Medication Regimens Used by US Adults With Hypertension and the Potential for Fixed‐Dose Combination Products: The National Health and Nutrition Examination Surveys 2015 to 2020
202313 citationsauthor #2
Hypertension Statistics for US Adults: An Open-Source Web Application for Analysis and Visualization of National Health and Nutrition Examination Survey Data
202338 citationsauthor #5
New Users of Angiotensin II Receptor Blocker–Versus Angiotensin‐Converting Enzyme Inhibitor–Based Antihypertensive Medication Regimens and Cardiovascular Disease Events: A Secondary Analysis of ACCORD‐BP and SPRINT
20232 citationsauthor #10
Abstract 13622: Association Between Self-Reported Medication Adherence and Therapeutic Inertia in Hypertension: A Secondary Analysis of the Systolic Blood Pressure Intervention Trial (SPRINT)
20230 citationsauthor #11
Abstract 14044: Association Between Home Diuretic Dose and Optimal Initial Intravenous Diuretic Dosing in Acute Decompensated Heart Failure
20230 citationsauthor #12
Single-Pill Combination Product Availability of the Antihypertensive Regimens Used for Intensive Systolic Blood Pressure Treatment in the Systolic Blood Pressure Intervention Trial
20233 citationsauthor #8
Estimated population health benefits of intensive systolic blood pressure treatment among SPRINT-eligible US adults.
20239 citationsauthor #2
Abstract 117: The Impact Of De-escalating Antihypertensive Drugs: A Secondary Analysis Of The Systolic Blood Pressure Intervention Trial (sprint)
20230 citationsauthor #3
Sleep Technology Intervention to Target Cardiometabolic Health (STITCH): a randomized controlled study of a behavioral sleep extension intervention compared to an education control to improve sleep duration, blood pressure, and cardiometabolic health among adults with elevated blood pressure/hyperte
20234 citationsauthor #4
Cost‐Effectiveness of Icosapent Ethyl in REDUCE‐IT USA: Results From Patients Randomized in the United States
20234 citationsauthor #6
Patterns, Prognostic Implications, and Rural-Urban Disparities in Optimal GDMT Following HFrEF Diagnosis Among Medicare Beneficiaries.
202313 citationsauthor #8
Association of New Use of Antihypertensives That Stimulate vs Inhibit Type 2 and 4 Angiotensin II Receptors With Dementia Among Medicare Beneficiaries
202322 citationsauthor #3
Abstract 16725: Cost-Effectiveness Analysis of Intensive Treatment of Systolic Hypertension: Results From Sprint Patient-Level Data
20230 citationsauthor #3
Identifying Patients for Intensive Blood Pressure Treatment Based on Cognitive Benefit
202322 citationsauthor #17
Abstract 11599: High-Density Lipoprotein Cholesterol and Statin Use for Primary Prevention Among US Adults With Intermediate 10-year Predicted ASCVD Risk
20230 citationsauthor #3
Longer-Term All-Cause and Cardiovascular Mortality With Intensive Blood Pressure Control: A Secondary Analysis of a Randomized Clinical Trial.
202259 citationsauthor #2
The potential population health impact of treating REDUCE-IT eligible US adults with Icosapent Ethyl
20228 citationsauthor #2
Potential impact of systematic and random errors in blood pressure measurement on the prevalence of high office blood pressure in the United States
202214 citationsauthor #4
USING ANTICOAGULANT EXPOSURE TO MEASURE PRESCRIBING PATTERNS AND BLEEDING IN CANCER PATIENTS WITH ATRIAL FIBRILLATION
20220 citationsauthor #5
Abstract 244: The Potential Population Health Impact Of Treating US Adults With Icosapent Ethyl.
20220 citationsauthor #2
LIPID-LOWERING THERAPY INTENSIFICATION AMONG UNITED STATES VETERANS FOLLOWING MYOCARDIAL INFARCTION OR CORONARY REVASCULARIZATION BETWEEN 2015 AND 2019
20220 citationsauthor #16
Identification of a SGCD x Discrimination interaction effect on systolic blood pressure in African American adults in the Jackson Heart Study.
20221 citationsauthor #3
Predicting Out-of-Office Blood Pressure in a Diverse US Population
20220 citationsauthor #11
Systolic Blood Pressure Time in Target Range and Major Adverse Kidney and Cardiovascular Events
202242 citationsauthor #6
Antihypertensive Medication Regimens Used in the Systolic Blood Pressure Intervention Trial
20225 citationsauthor #2
Association of Intensive vs Standard Blood Pressure Control With Cerebral Blood Flow: Secondary Analysis of the SPRINT MIND Randomized Clinical Trial.
202258 citationsauthor #18
Association of Antihypertensives That Stimulate vs Inhibit Types 2 and 4 Angiotensin II Receptors With Cognitive Impairment
202230 citationsauthor #16
Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, and COVID-19-related outcomes: A patient-level analysis of the PCORnet blood pressure control lab
20224 citationsauthor #9
Cost-effectiveness of Icosapent Ethyl for High-risk Patients With Hypertriglyceridemia Despite Statin Treatment
202221 citationsauthor #6
An efficient approach for optimizing the cost-effective individualized treatment rule using conditional random forest
20224 citationsauthor #3
Rare coding variants in RCN3 are associated with blood pressure
20223 citationsauthor #11
Lipid-Lowering Therapy Use and Intensification Among United States Veterans Following Myocardial Infarction or Coronary Revascularization Between 2015 and 2019
202215 citationsauthor #15
Abstract 170: Cost-effectiveness Of Icosapent Ethyl In Reduce-it USA: Results From Patients Randomized In The United States
20220 citationsauthor #5
Analysis of Therapeutic Inertia and Race and Ethnicity in the Systolic Blood Pressure Intervention Trial: A Secondary Analysis of a Randomized Clinical Trial
202223 citationsauthor #12
Genetic European Ancestry and Incident Diabetes in Black Individuals: Insights From the SPRINT Trial
20227 citationsauthor #4
Do Prediction Models Do More Harm Than Good?
20224 citationsauthor #2
Insights From a Large-Scale Whole-Genome Sequencing Study of Systolic Blood Pressure, Diastolic Blood Pressure, and Hypertension
202222 citationsauthor #29
Asymptomatic hypertension in the hospital setting: primum non nocere
20223 citationsauthor #3
Association of Polygenic Risk Score With Blood Pressure and Adverse Cardiovascular Outcomes in Individuals With Type II Diabetes: Insights From the ACCORD Trial.
20222 citationsauthor #3
Risk of Mild Cognitive Impairment or Probable Dementia in New Users of Angiotensin II Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors
202212 citationsauthor #17
Prevalence, risk factors, and cardiovascular disease outcomes associated with persistent blood pressure control: The Jackson Heart Study
20225 citationsauthor #4
Association of colorectal cancer with genetic and epigenetic variation in PEAR1—A population-based cohort study
20223 citationsauthor #3
Intensive Versus Standard Blood Pressure Lowering and Days Free of Cardiovascular Events and Serious Adverse Events: a Post Hoc Analysis of Systolic Blood Pressure Intervention Trial
20221 citationsauthor #8
Can Preferentially Prescribing Angiotensin II Receptor Blockers (ARBs) over Angiotensin-Converting Enzyme Inhibitors (ACEIs) Decrease Dementia Risk and Improve Brain Health Equity?
20224 citationsauthor #5
Abstract 11668: Trends in Statin Use for Primary Prevention by Race/Ethnicity and ASCVD Risk in the US: 2013-2020
20220 citationsauthor #12
Rare coding variants in RCN3 are associated with blood pressure
20220 citationsauthor #11
Cost-Effectiveness of Masked Hypertension Screening and Treatment in US Adults With Suspected Masked Hypertension: A Simulation Study
20224 citationsauthor #4

TIMELINE

2011 17 citations

2012 61 citations

2013 153 citations

2014 54 citations

2015 225 citations

2016 561 citations

2017 799 citations

2018 489 citations

2019 312 citations

2020 328 citations

2021 204 citations

2022 354 citations

2023 283 citations

2024 116 citations

2025 194 citations

2026 1 citations

Unknown 42 citations

A. Bress

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT